Literature DB >> 21168723

B-type natriuretic peptide pretreatment attenuates heart ischemia-reperfusion injury in rats.

B Ren1, H Wu, R Yin, L Xu, H Jing, M Li, F Jiang, Z Wang.   

Abstract

BACKGROUND: Graft dysfunction following transplantation is due to ischemia-reperfusion (IR) injury. B-type natriuretic peptide (BNP) has been shown to attenuate ischemia-reperfusion (IR) injury in animals. We designed this experiment to evaluate the effects of BNP pretreatment on IR-induced heart injury.
METHODS: A rat model of myocardial IR injury was established by ligating the left descending coronary artery for 30 minutes before a 2-hour reperfusion. We randomly divided 47 Sprague-Dawley rats into six groups: sham operation (n = 6), IR (n = 9), IR + BNP 0.001 μg/(kg·min; n = 8); IR + BNP 0.005 μg/(kg·min; n = 8); IR + BNP 0.01 μg/(kg·min; n = 8); and IR + BNP 0.03 μg/(kg·min; n = 8). During the processes, lead ECG was traced continuously to note arrhythmias caused by reperfusion. Serum levels of creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH) were measured at 2 hours after reperfusion.
RESULTS: The BNP-treated animals showed a significantly reduced incidence of ventricular arrhythmias caused by reperfusion (P < .05). They showed a dosage-dependent marked decrease in levels of serum CK-MB and LDH compared with the IR only group (P < .05).
CONCLUSIONS: BNP pretreatment protected the myocardium of rats against IR injury, in a dose-dependent manner.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168723     DOI: 10.1016/j.transproceed.2010.09.163

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis.

Authors:  Ming-Yi Lv; Shu-Ling Deng; Xiao-Feng Long
Journal:  Br J Clin Pharmacol       Date:  2015-11-28       Impact factor: 4.335

2.  Anti-inflammatory effect of B-type natriuretic peptide postconditioning during myocardial ischemia-reperfusion: involvement of PI3K/Akt signaling pathway.

Authors:  Gangying Hu; Xingyue Huang; Kai Zhang; Hong Jiang; Xiaorong Hu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

3.  Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion.

Authors:  Bochra Tourki; Philippe Matéo; Jessica Morand; Mohamed Elayeb; Diane Godin-Ribuot; Naziha Marrakchi; Elise Belaidi; Erij Messadi
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.